drugset / Trial / NCT05273528
The Immunogenicity and Safety of V-01-351/V-01D Bivalence Vaccine
NaSingle-groupOpen-labelPrevention
Summary
It is a Single Arm, Open Label Clinical Study to Evaluate the Immunogenicity and Safety of Sequential Immunization of V-01-351/V-01D Bivalence Vaccine in Healthy Adults Aged 18 Years and Older After the Vaccination of 2 Doses of Inactivated Vaccines. A total of 20 participants were enrolled.
Timeline
- Start
- 2022-01-11
- Primary completion
- 2023-01-06
- Completion
- 2023-01-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | V-01-351/V-01D Bivalence Vaccine | Vaccine | — | Other |